FASN and breast cancer: Lipid metabolism is a major determinant of therapeutic resistance, with fatty acid synthase (FASN) overexpression inducing resistance to various drugs, including adriamycin and mitoxantrone, in breast cancer cells [163] and radiotherapy-resistant head and neck squamous cell carcinomas [164].